Discontinuation report SCANDONEST 2% WITH LEVONORDEFRIN
| Report ID | 204399 |
| Drug Identification Number | 02313863 |
| Brand name | SCANDONEST 2% WITH LEVONORDEFRIN |
| Common or Proper name | Corbadrine and Mepivacaine HCl solution |
| Company Name | NOVOCOL PHARMACEUTICAL OF CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CORBADRINE MEPIVACAINE HYDROCHLORIDE |
| Strength(s) | 0.05MG 20MG |
| Dosage form(s) | SOLUTION |
| Route of administration | BLOCK/INFILTRATION |
| Packaging size | Box of 50 Cartridges of 1.8 mL each |
| ATC code | N01BB |
| ATC description | ANESTHETICS, LOCAL |
| Reason for discontinuation | Raw material availability |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2023-03-20 |
| Remaining supply date | 2023-03-20 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 25 WOLSELEY COURT CAMBRIDGE, ONTARIO CANADA N1R 6X3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2023-09-15 | French | Compare |
| v1 | 2023-09-15 | English | Compare |
Showing 1 to 2 of 2